期刊文献+

多西他赛联合顺铂、氟尿嘧啶化疗致重度骨髓抑制及低钾血症 被引量:4

Severe bone marrow suppression and hypokalemia caused by docetaxel cisplatin and fluorouracil chemotherapy
暂未订购
导出
摘要 1例60岁男性胃癌晚期患者,给予多西他赛联合顺铂、氟尿嘧啶化疗,第6天开始出现骨髓抑制,第9天达到高峰,白细胞降至0.73×109.L-1,血小板最低39×109.L-1;同时合并高热及重度低钾血症,血钾最低1.98 mmol.L-1。给予皮下注射重组人粒细胞集落刺激因子、氯化钾注射液持续静脉泵入、预防感染及退热对症处理,患者第12天体温恢复正常,第15天白细胞、血小板及血钾恢复正常。患者安全度过危险期,顺利出院。 One case of 60-year-old male patient with advanced gastric cancer, was treated with docetaxel cisplatin and fluorouracil chemotherapy, bone marrow suppression emerged on the sixth day, and peaked on day 9. WBC counts decreased to 0.73 × 10^9.L^-1, platelet minimum decreased to 39 x 109.L^-1, combined with hyperpyrexia and severe hypokalemia and potassium minimum decreased to 1.98 mmol.L^-1. After subcutaneous injection of subcutaneously recombinant human granulocyte colony stimulating factor and potassium chloride injection pump continuously into veins and prophylactic measurements of infection and abatement of fever, his temperature returned to normal on day 12, WBC and platelet count returned to normal on day 15. The patient passed the critical stage successfully, and was discharged.
出处 《中国药物应用与监测》 CAS 2012年第2期123-124,共2页 Chinese Journal of Drug Application and Monitoring
关键词 化疗 骨髓抑制 低钾血症 Chemotherapy Bone marrow suppression Hypokalemia
  • 相关文献

参考文献7

  • 1Zhao P,Dai M,Chen W. Cancer trends in China[J].Clinical Oncology,2010,(04):281-285.
  • 2Ajani JA,Moiseyenko VM,Tjulandin S. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase trial for advanced gastric or gastroesophageal adenocarcinoma:the V2325 study group[J].Clinical Oncology,2007,(22):3210-3216.
  • 3Minamide J,Aoyama N,Takada K. Evaluation of docetaxel,CDDP and 5-Fu combined therapy as second line chemotherapy for esophagus cancer[J].Gan To Kagaku Ryoho(Japanese Journal of Cancer and Chemotherapy),2007,(01):49-52.
  • 4向英.氟尿嘧啶致重度骨髓抑制1例[J].中国煤炭工业医学杂志,2009,12(1):151-151. 被引量:3
  • 5刘新春;程玉峰.实用抗肿瘤药物治疗学[M]北京:人民卫生出版社,20021075.
  • 6程斌,翁琳,王增.化疗引起Ⅳ度骨髓抑制的临床观察与分析[J].中国药房,2010,21(14):1310-1312. 被引量:20
  • 7李德冠,孟爱民.造血干细胞衰老机制研究[J].中国药理学通报,2008,24(6):701-704. 被引量:13

二级参考文献32

  • 1谭永红,曾仁杰,王诗华,段艳冰,梁蓉梅.临床药师应重视肿瘤患者的药疗监护[J].中国药房,2004,15(12):763-764. 被引量:18
  • 2石远凯,周际昌,冯奉仪,曾万勇,李青,何小慧,张弘刚,张湘茹,周立强.基因重组人粒细胞集落刺激因子对肿瘤化疗所致白细胞减少的临床疗效观察[J].中华肿瘤杂志,1994,16(3):207-210. 被引量:35
  • 3王传金,纪秀英.肿瘤化疗药物的不良反应[J].现代肿瘤医学,2006,14(10):1321-1323. 被引量:30
  • 4Peterson DE. Pretreatment strategies for infection prevention in chemotherapy patients[J]. NCI Monogr, 1990, 9: 61.
  • 5Urabe A. Bone marrow suppression[J]. Nippon Rinsho, 2003,61(6) :949.
  • 6Markman M.Managing taxane toxicities[J].Supportive Care in Cancer,2003,11(3) : 144.
  • 7Linton P J, Dorshkind K. Age-related changes in lymphocyte development and function [ J ]. Nature Immunol, 2004,5 (2) : 133 - 9.
  • 8Lichtman M A, Rowe J M. The relationship of patient age to the pathobiology of the clonal myeloid diseases [ J ]. Semin Oncol, 2004,31(2) :185 -97.
  • 9Kollman C, Howe C W, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age[J]. Blood, 2001, 98(7) :2043 -51.
  • 10Allsopp R C, Weissman I L. Replicative senescence of hematopoietic stem cells during serial transplantation : does telomere shortening play a role[J] ? Oncogene, 2002,21(21 ) :3270 -3.

共引文献32

同被引文献35

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部